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Abstract
The recent focus on the potential link between periodontal and cardiovascular disease (PD 
and CVD)  is part of the larger renewed interest on the role of infection and inflammation in 
the  etiology  of  atherosclerosis  a
inflammatory process affecting the periodontium, the tissue that surrounds and supports the 
teeth. The process usually starts with an inflammatory process of the gum (gingivitis) but it 
may progress with an extensive involvement of the gum, as well as the periodontal ligament 
and the bone surrounding the teeth resulting in substantial bone loss. Periodontal disease is a 
common oral pathological condition in the adult age and represents the leading c
loss.  PD  prevalence  increases  with  age  and  there  are  estimates  that  up  to  49,000,000 
Americans may suffer from some form of gum disease. The gingival plaque associated with 
PD is colonized by a number of gram
shown  to  affect  the  initiation  and  development  of  PD  and  have  been  associated  with  the 
potential etiological role of PD in CVD and other chronic conditions. A potential etiological 
link  between  PD  and  CVD  may  have  important  public  health 
exposure (PD) and the outcomes (CVD) are highly prevalent in industrialized societies. In 
situations in  which  both  the  exposure  and  the  outcome  are  highly prevalent  even  modest 
associations, like those observed in the studies repor
outcomes,  may have  relevance. There  are   not    definite  data  on  the  effect  of periodontal 
treatment on CVD clinical outcomes (either in primary or secondary prevention) however it 
should  be  pointed  out  that  the  limited  (b
experimental evidence in humans suggests a possible beneficial effect of periodontal treatment 
of indices of functional and structural vascular health.
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PD is colonized by a number of gram-positive and gram-negative bacteria that have been 
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situations in  which  both the  exposure  and the  outcome  are  highly prevalent  even  modest 
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outcomes,  may have  relevance.  There  are   not   definite  data  on the  effect  of periodontal 
treatment on CVD clinical outcomes (either in primary or secondary prevention) however it 
should  be  pointed  out  that  the  limited  (both  in  terms  of  numbers  and  study  design) 
experimental evidence in humans suggests a possible beneficial effect of periodontal treatment 
of indices of functional and structural vascular health.
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Introduction: The recent focus on the potential link 
between periodontal and cardiovascular disease (PD 
and CVD)  is part of the larger renewed interest on 
the  role  of  infection  and  inflammation  in  the 
etiology  of  atherosclerosis  and  its  clinical 
manifestations.  In this review, we will describe the 
potential mechanisms that have been identified and 
review  the  evidence  from  observational  and 
intervention studies.
Periodontal Disease is an inflammatory process 
affecting the periodontium, the tissue that surrounds 
and supports the teeth . The process usually starts 
with  an  inflammatory  process  of  the  gum 
(gingivitis)  but it  may  progress  with  an extensive 
involvement of the gum, as well as the periodontal 
ligament  and  the  bone  surrounding  the  teeth 
resulting  in  substantial  bone  loss.  Periodontal 
disease is a common oral pathological condition in 
the adult  age  and represents  the  leading  cause  of 
tooth  loss. PD  prevalence  increases  with  age  and 
there are estimates that up to 49,000,000 Americans 
may suffer from some form of gum disease. 
A hallmark of PD is the presence of bacteria in 
the gingival plaque (both supra- and sub-gingival) 
that  characterizes  the  periodontal  pathological 
process. The oral cavity is colonized by hundreds of 
bacteria, most of which have no clear pathological 
effects; however the gingival plaque associated with 
PD is colonized by a number of gram-positive and 
gram-negative  bacteria  that  have  been  shown  to 
affect  the  initiation  and  development  of  PD  and 
have been associated with the potential etiological 
role of PD in CVD and other chronic conditions.
Mechanisms: A number of mechanisms have been 
hypothesized  to  explain  the potential  pathological 
role of periodontal disease in cardiovascular disease 
etiology.    These  include:  a)  potential  direct 
mechanisms  on  the  vessel  wall  and  the 
atherosclerotic plaque and b) indirect mechanisms. 
Direct  Mechanisms: This hypothesis assumes that 
bacteria  or  their  products  access  the  vessel  wall 
(endothelium)  directly,  through  the  blood  stream, 
and affect either the formation of the plaque and/or 
its  evolution.    In  support  of  this  hypothesis  a 
number of studies have shown evidence of presence 
of viable oral bacteria or their genetic material in 
atheromatous  plaque  samples  from  different 
vascular beds.
1-4 However, not all the studies have 
confirmed these findings.
5,6
Indirect Mechanisms: Indirect mechanisms through 
which  PD  can  affect  CVD  include  the  potential 
effects on a number  of classical CVD risk factors 
like  total  and  LDL  serum  cholesterol,  blood 
pressure,  glucose  metabolism  and  platelet 
aggregation.  A  number  of  observational  studies 
have  shown  significant  associations  between  PD 
and serum total cholesterol
7-9 and PD and glucose 
metabolism,
10,11 the  observational    association 
between  PD  and  blood  pressure  has  been  less 
investigated;
12 however a small randomized clinical 
trial  has  shown  significant  effects  of  periodontal 
therapy on both these risk factors.
13 No consistent 
evidence has been generated supporting an effect of 
PD on either HDL or triglycerides. The mechanisms 
underlying these effects are not  clear but  may be 
related to the effect of PD on endothelial function or 
the  inflammatory  process.  An  additional 
mechanisms through which PD can affect CVD is 
through an effect on platelet aggregation.
14
Substantial  efforts  have  been  dedicated  to 
investigate  the  role  of  inflammation and  its 
biomarkers in the link between PD and CVD.
As previously indicated hallmarks of PD are the 
presence  of  bacteria  and  the  local  inflammatory 
process.
15 There  are  strong  indications  that  the 
periodontal pocket can act as the port of entry in the 
organism  of  both  bacteria  and  their  products  and 
inflammatory and pro-inflammatory mediators. The 
result, either through transient bacteremia or direct 
access  to  the  blood  stream  of  inflammatory 
mediators, is a generalized inflammatory process. 
An  additional  mechanism  that  has  been 
hypothesized to play a role in the link between PD 
and CVD is molecular mimicry.
16 This hypothesis is 
based on the relevance of the immune response in 
atherogenesis.  According  to  this  hypothesis 
bacterial  products  and/or  inflammatory  mediators 
may  induce  the  endothelium  to  produce  host 
protective  factors  against  the  bacterial heat  shock 
proteins  (HSP).  This    immune  response  targeted 
against  specific  HSP  antigens  in  plaques  may 
exacerbate  the  established  inflammation  thereby 
promoting atherosclerotic  plaque  progression  and 
stability.
The  exposure: The  measurements  of  Periodontal 
disease/health that have been utilized to date vary 
substantially, and include: general measurements of 
oral  health,  crude  measurements  of  self-reported 
missing  teeth,  standardized  measurements  of 
gingival  detachment  (periodontal  pockets), 
radiographic  measurements of bone loss and more 
recently  measurements  of  bacterial  infection.  The 
interpretation of the literature is complicated by the 
lack of an agreement on a clear definition of PD in Medit J Hemat Infect Dis 2010; 2(3); Open Journal System 
the  scientific  community.  In  general  there  is 
consistency  in  findings  across  studies  using 
different  indices  of  PD  and  the  studies  that  have 
used  more  detailed  measurements  of  exposures 
have,  in  general,  showed  stronger  association 
between PD and CVD outcomes.
The  outcomes: Different  outcomes  have  been 
investigated and include both clinical outcomes (i.e. 
Coronary  Heart  Disease,  Myocardial  Infarction, 
Acute Coronary Syndrome, and Stroke) as well as 
non-invasive  measurements  of  subclinical 
atherosclerosis [i.e. carotid intima media thickness 
(IMT) and endothelial dysfunction]. 
In addition to these disease related outcomes a 
number  of  studies  (both  observational  and 
intervention  in  nature)  have  investigated  the 
relationship  between  PD  and  a  wide  array  of 
cellular  and plasma  markers  of  inflammation  (i.e. 
White blood cells, CRP, cytokines).
  
The evidence
Observational  Studies: The  evidence  to  date 
relating PD to clinical outcomes is based solely on 
observational studies. These studies include clinical 
comparisons  of  selected  samples,  retrospective 
(case-control)  and  longitudinal  epidemiological 
studies.
Coronary Artery Disease: A total of approximately 
sixty studies have focused on cardiac outcomes (i.e. 
CHD,  MI  or  ACS)  and  provided  quantitative 
assessment of risk. The majority but not all these 
studies show a significant association between PD 
and  these  clinical  outcomes.  Many  of  the  studies 
presented multivariate adjusted estimates indicating 
that the relationship may be independent from the 
potential  confounding  effect  of  socio-economic 
factors,  life  style  habits  like  smoking  and  other 
important  covariates.    This  association  has  been 
consistently found in studies from different parts of 
the  world  and  in  both  men  and  women.  The 
evidence  in  women  is  much  more  limited  but  a 
study that focused on both sexes provided evidence 
for  a  potentially  higher  risk  of  MI  in  women 
compared to men.
17 The increased risk of coronary 
events in individuals with PD has been shown both 
in subjects with and without pre-existing CVD.
18-22
Several  reviews  have  indicated  an  overall 
significant  association  between  PD  and  coronary 
outcomes,  two  more  recent  systematic  reviews 
indicated that relative risk estimates ranged from a 
24%  to  a  34%  increased  risk  and  that  these 
estimates  were  consistent  across  the  various 
methods  to  ascertain  both  PD  and  coronary 
events.
23-24
Stroke: The amount of articles reporting on the link 
between PD and cerebrovascular outcomes are more 
limited but, as for coronary outcomes, the overall 
evidence is in support of a positive association. The 
evidence  appears  to  be  stronger  for  studies  with 
more detailed measures of PD and to be present for 
both  fatal  and  non  fatal  events.
25-28 A  study  that 
analyzed  both  hemorrhagic  and  non  hemorrhagic 
stroke  reported  a  significant  association  with  the 
latter and not the former outcome, providing some 
evidence  of  the specificity  of  the  association  in 
agreement with the postulated mechanisms.
26
Non  invasive  measurements  of  atherosclerosis:  A 
number of studies have investigated the relationship 
between structural [carotid intima media thickness 
(IMT)]  and  functional  measurements  of  vascular 
health  and  PD.  The  most  convincing  evidence 
regarding  structural  changes  comes  from 
epidemiological studies showing a significant cross-
sectional  association  between  periodontitis  and 
carotid  IMT  in  multivariate  analyses.
29-30 One  of
these  two  studies  however  failed  to  find  a 
significant association between indices of PD and 
coronary  calcium  scores  in  a  small  subgroup 
(n=269) of the same population study.
31
Functional  measurements  of  vascular  health 
have been the focus of several studies, in general 
small clinical samples, all have shown a significant 
positive association between PD and vascular health 
(i.e. brachial reactivity).
32-34
The role of smoking: Smoking is an important risk 
factor for both PD and CVD. The strong association 
between  smoking  and  these  two  conditions  has 
raised concern over the true nature of the observed 
association between PD and CVD outcomes. Some, 
in  fact had argued that because of  the  strong co-
linearity among these three variables it is basically 
impossible to address the independent nature of the 
relationship  between  PD  and  CVD  through 
multivariate  adjustment  (i.e.  residual 
confounding).
35 This  important  concern  has  been 
addressed  by  recent  studies.  In  particular,  a 
longitudinal investigation on the link between PD 
and mortality in a large sample of native American 
Indians with type 2 diabetes (with low prevalence 
of smoking and no difference in smoking between 
individuals  with  and  without  PD)  showed  a 
significant association between PD and cardio renal 
deaths.
36 In  addition  a  recent  a  longitudinal Medit J Hemat Infect Dis 2010; 2(3); Open Journal System 
investigation,  linking  serum  immunoglobulin  G 
antibodies  against  oral  bacteria  to  carotid  IMT,
37
and a population based  case-control study linking 
periodontal pockets to incident acute MI found the 
association to be present both in smokers and never 
smokers.
17 And  finally  in  a  population-based 
prospective  study  of  more  than  800  incident 
myocardial  infarction  survivors,  PD,  measured  as 
clinical  attachment  loss,  was  associated  with  an 
approximately    40%  increased  risk  of  recurrent 
CVD  events  (fatal,  non-fatal  CVD  or  cardiac 
revascularizations)  in  patients  who  never  smoked 
cigarettes.
22 These data indicate that the association 
between  PD  and  CVD  cannot  be  the  result  of 
confounding by smoking.
Intervention Studies: No studies to date have been 
published  investigating  the  role  of  periodontal 
treatment on clinical outcomes.
Several  intervention  studies  have  been 
conducted  to  investigate  the  effect  of  various 
periodontal  treatments  on  either  biomarkers  of 
inflammation and vascular health.
Periodontal  treatment  and  Inflammation 
markers: The  studies  with  a  randomized  design 
and  using  a  control  group  do  not  demonstrate 
consistent  effects  of  periodontal  intervention  on 
inflammatory  markers,  in  particular  CRP.
38-40 A 
recent report from a large multicenter pilot study to 
investigate the feasibility of a secondary prevention 
trail  of  PD  treatment  in  cardiovascular  disease 
patients confirmed the overall lack of an effect of 
PD  treatment  on  CRP  and  suggested  that  the 
potential effect of PD treatment on CRP and other 
markers  of  inflammation  could  be  mediated  by 
obesity.
41 These  findings  raise  doubts  on  the 
importance  of  CRP  in  mediating  the  observed 
relationship between PD and CVD.
Periodontal treatment and vascular health: Few 
studies have been conducted to ascertain the effect 
of  PD  on  a  number  of  indicators  of  functional 
vascular health, these includes three small clinical 
studies (without placebo group) and a randomized 
controlled  trial.
34,42,43 All  studies  show  consistent 
findings of an improvement in endothelial function 
(flow mediated brachial dilation) after PD treatment 
The randomized controlled trial
43  showed  that the 
effects on vascular health was dose-dependent (i.e. 
correlation between the clinical effects on PD and
the improvement in vascular health). In addition the 
study showed a possible transient worsening of the 
vascular health following PD treatment, possibly as 
a result of a sudden increase in the circulatory level 
of  the  inflammatory  biomarkers  secondary  to  the 
mechanical  removal  of  the  periodontal  plaque. 
Finally a recent small  non controlled intervention 
study showed evidence for a potential benefit of PD 
treatment on structural markers of vascular health 
(IMT).
44
Summary: A potential etiological link between PD 
and  CVD  may  have  important  public  health 
implications  as  both  the  exposure  (PD)  and  the 
outcomes  (CVD)  are  highly  prevalent  in 
industrialized societies. In situations in which both 
the exposure and the outcome are highly prevalent 
even modest associations, like those observed in the 
studies reporting on the link between PD and CVD 
outcomes, may have relevance.
If we consider the criteria for establishing the 
cause-effect relationship of an observed association, 
we  can  conclude  that  the  observed  association 
between PD and CVD outcomes satisfies most of 
these criteria. In particular, studies (individual and 
systematic  reviews)  to  date  have  shown  the 
association  to  be  significant,  consistent across 
different study designs and settings, specific to the 
hypothesized  outcome  based  on  postulated 
mechanisms,  longitudinal  studies  have  confirmed 
the  temporal  relationship  between  exposure  and 
outcomes,  elegant  mechanisms  have  been 
hypothesized and confirmed to show the plausibility
of the association that is coherent with the results of 
the  laboratory  evidence.  Unfortunately  we  are 
missing, what is considered by many the strongest 
of the criteria i.e. definite evidence that the outcome 
can be altered (prevented or treated) by intervening 
on the exposure. As previously indicated, we have 
no  definite  data  on  the  effect  of  periodontal 
treatment  on  CVD  clinical  outcomes  (either  in 
primary or secondary prevention) however it should 
be  pointed  out  that  the  limited  (both  in  terms  of 
numbers  and study design)  experimental  evidence 
in humans suggests a possible beneficial effect of 
periodontal treatment of  indices of  functional and 
structural  vascular  health.  These  same  studies 
however have raised concerns regarding the role of 
inflammation and its markers as an important link 
between  PD  and  CVD;  in  particular,  the  role  of 
CRP has been called to question by the available 
experimental evidence.
Conclusions:  The  link  between  PD  and  CVD  is 
worth investigating because of its potential public 
health implications, the evidence to data has been 
shown to fulfill most of the criteria established for Medit J Hemat Infect Dis 2010; 2(3); Open Journal System 
determining  a  cause-effect  relationship.  The 
observed  association  appears  to  be  independent 
from  the  potential  confounding  role  of  important 
covariates (especially smoking); studies need to be 
conducted  to  better  understand  the 
pathophysiological links between PD and CVD and 
this  improved  knowledge  regarding  the  pathways 
should  guide  the  design  of  specific  intervention 
studies  aimed  at  providing definite  proof that  we 
can,  through  periodontal  treatment,  affect  CVD 
clinical outcomes.  
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